Brief: Artivion Says Endospan Receives Additional $25 Mln From Co For Nexus FDA Approval Path
July 2 (Reuters) - Artivion Inc AORT.N :
* ENDOSPAN RECEIVES ADDITIONAL $25M FROM ARTIVION FOR NEXUS
FDA
APPROVAL PATH
Source text for Eikon: ID:nPn6QbVbna
Further company coverage: AORT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Artivion
See all newsUS RESEARCH ROUNDUP-Axon Enterprise, Williams-Sonoma, Xcel Energy
Artivion Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Artivion Q2 Revenue USD 125.757 Million Vs. IBES Estimate USD 120 Million
U.S. RESEARCH ROUNDUP-Applied Materials, McDonald's, McKesson
Artivion Q1 revenue slightly beats, cuts 2026 outlook